Molecular analysis of IDH1/2 mutations and MGMT promoter methylation in gliomas and meningiomas

被引：0
|
作者：
Saetta, A. [1 ]
Gioti, A. [1 ]
Chatziandreou, I. [1 ]
Tsioli, P. [1 ]
Soldatos, R. F. [1 ]
Sakellariou, S. [1 ]
Samaras, V. [1 ]
Sepsa, A. [1 ]
Zisakis, A. [1 ]
Korkolopoulou, P. [1 ]
Patsouris, E. [1 ]
机构：
[1] Univ Athens, Dept Pathol 1, GR-10679 Athens, Greece
来源：
VIRCHOWS ARCHIV | 2013年 / 463卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：319 / 319
页数：1
相关论文
共 50 条
  • [1] The Analysis of IDH1 Mutation and MGMT Promoter Methylation in Malignant Gliomas
    Takahashi, Yoshinobu
    Nakamura, Hideo
    Makino, Keishi
    Hide, Takuichirou
    Muta, Daisuke
    Kuratsu, Jun-ichi
    JOURNAL OF NEUROSURGERY, 2012, 117 (02) : A445 - A445
  • [2] PROGNOSTIC OR PREDICTIVE VALUE OF MGMT PROMOTER METHYLATION IN MALIGNANT GLIOMAS DEPENDS ON IDH1 MUTATIONS
    Wick, W.
    Meisner, C.
    Hentschel, B.
    Platten, M.
    Sabel, M.
    Koeppen, S.
    Ketter, R.
    Simon, M.
    Reifenberger, G.
    Weller, M.
    NEURO-ONCOLOGY, 2012, 14 : 7 - 7
  • [3] Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation
    Wick, Wolfgang
    Meisner, Christoph
    Hentschel, Bettina
    Platten, Michael
    Schilling, Alissa
    Wiestler, Benedikt
    Sabel, Michael C.
    Koeppen, Susanne
    Ketter, Ralf
    Weiler, Markus
    Tabatabai, Ghazaleh
    von Deimling, Andreas
    Gramatzki, Dorothee
    Westphal, Manfred
    Schackert, Gabriele
    Loeffler, Markus
    Simon, Matthias
    Reifenberger, Guido
    Weller, Michael
    NEUROLOGY, 2013, 81 (17) : 1515 - 1522
  • [4] Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas
    Zhang, Jie
    Yang, Jian-hui
    Quan, Jia
    Kang, Xing
    Wang, Hui-juan
    Dai, Peng-gao
    TUMOR BIOLOGY, 2016, 37 (10) : 13571 - 13579
  • [5] Developing and Validating an LDT for IDH1/2 Mutations and MGMT Methylation
    Hudzik, C.
    Yan, L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S12 - S13
  • [6] IDH1/2 Mutation and MGMT Promoter Methylation - the Relevant Survival Predictors in Czech Patients with Brain Gliomas
    Kramar, F.
    Minarik, M.
    Benesova, L.
    Halkova, T.
    Netuka, D.
    Bradac, O.
    Benes, V.
    FOLIA BIOLOGICA, 2016, 62 (05) : 194 - 202
  • [7] ANGIOCENTRIC GLIOMAS ARE CHARACTERIZED BY UNMETHYLATED MGMT-PROMOTER AND DO NOT HARBOR BRAF OR IDH1/2 MUTATIONS
    Capper, D.
    Felsberg, J.
    Hainfellner, J.
    Pannek, H. W.
    Preusser, M.
    Hans, V. H.
    EPILEPSIA, 2013, 54 : 319 - 320
  • [8] SOCS1 Methylation is Associated to MGMT Methylation and IDH1 Mutation in Gliomas
    Irles Vidal, E.
    Alenda, C.
    Egoavil, C.
    Garcia-Martinez, A.
    Hernandez-Illan, E.
    Martinez-Canto, A.
    Castillejo, M. I.
    Quintanar, T.
    Castillejo, A.
    Barbera, V. M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S136 - S136
  • [9] Combinational analysis of IDH1/IDH2 mutations, 1p/19q deletions and MGMT promoter methylation for molecular testing of glioma.
    Zhang, Xiaoni
    Qu, Hongyue
    Yang, Qing
    Zhu, Ziyang
    Huang, Tanxiao
    Chen, Shifu
    Edwards, Jeremy
    Xu, Mingyan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] IDH1 and IDH2 Mutations in Gliomas
    De Carli, Emilie
    Wang, Xiaowei
    Puget, Stephanie
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (21): : 2248 - 2248
12345